Chapter 2 — CONTROLLED SUBSTANCES.
- Section 20-2-1 Short title.
- Section 20-2-2 Definitions.
- Section 20-2-3 Immunity of persons reporting suspected use, etc., of controlled substance by minor child.
- Section 20-2-20 Administration of chapter.
- Section 20-2-21 Nomenclature of controlled substances in schedules.
- Section 20-2-22 Schedule I - Standards for compilation.
- Section 20-2-23 Schedule I - Listing of controlled substances.
- Section 20-2-24 Schedule II - Standards for compilation.
- Section 20-2-25 Schedule II - Listing of controlled substances.
- Section 20-2-26 Schedule III - Standards for compilation.
- Section 20-2-27 Schedule III - Listing of controlled substances.
- Section 20-2-28 Schedule IV - Standards for compilation.
- Section 20-2-29 Schedule IV - Listing of controlled substances.
- Section 20-2-30 Schedule V - Standards for compilation.
- Section 20-2-31 Schedule V - Listing of controlled substances.
- Section 20-2-32 Revision and republication of schedules.
- Section 20-2-50 Certifying boards to promulgate rules and charge reasonable fees for registration and administration of provisions relating to manufacture, etc., of controlled substances; disposition
- Section 20-2-51 Registration of persons manufacturing, distributing or dispensing controlled substances - General requirements.
- Section 20-2-52 Registration of persons manufacturing, distributing or dispensing controlled substances - Standards; requirements as to practitioners conducting research; effect of federal registratio
- Section 20-2-53 Registration of persons manufacturing, distributing or dispensing controlled substances - Order to show cause; proceedings; review; issuance of stay.
- Section 20-2-54 Registration of persons manufacturing, distributing or dispensing controlled substances - Revocation or suspension of registration - Grounds and procedure generally.
- Section 20-2-54.1 Rules and regulations.
- Section 20-2-55 Registration of persons manufacturing, distributing or dispensing controlled substances - Revocation or suspension of registration - Suspension without prior order to show cause.
- Section 20-2-56 Maintenance of records and inventories by registrants generally.
- Section 20-2-57 Distribution of certain controlled substances by one registrant to another registrant.
- Section 20-2-58 Dispensing of controlled substances in Schedule II; maintenance of records and inventories by registered pharmacies.
- Section 20-2-60 Definitions.
- Section 20-2-61 Certification; access to records; establishment of protocols, formularies, or medical regimens.
- Section 20-2-62 Qualifications for certificate.
- Section 20-2-63 Prescriptive authority of a certified assistant to physician.
- Section 20-2-64 Denial of application.
- Section 20-2-65 Disciplinary action - Hearing; restriction, suspension, or revocation of certificate.
- Section 20-2-66 Disciplinary action - Judicial review.
- Section 20-2-67 Fees; costs; administrative fines.
- Section 20-2-68 Liability for actions regarding investigations or disciplinary proceedings.
- Section 20-2-69 Promulgation of rules.
- Section 20-2-71 Prohibited acts B.
- Section 20-2-72 Prohibited acts C.
- Section 20-2-74 Prescription, administration, etc., of controlled substances by practitioners of veterinary medicine for use of human beings or by practitioners of dentistry for persons not under trea
- Section 20-2-78 Penalties imposed for violations of chapter in addition to other civil or administrative penalties or sanctions.
- Section 20-2-90 State Board of Pharmacy, Department of Public Safety, etc., to enforce chapter; drug inspectors to meet minimum standards.
- Section 20-2-91 Inspection of stocks of controlled substances and prescriptions, orders, etc., required by chapter; disclosure of information as to prescriptions, orders, etc., by enforcement personne
- Section 20-2-92 Injunctions.
- Section 20-2-93 Forfeitures; seizures.
- Section 20-2-110 Short title.
- Section 20-2-111 Legislative findings; cannabis research.
- Section 20-2-112 Definitions.
- Section 20-2-113 Controlled Substances Therapeutic Research Program - Established; review committee; rules and regulations; formulation with federal agencies.
- Section 20-2-114 Controlled Substances Therapeutic Research Program - Limited to cancer chemotherapy and glaucoma patients; certification; exemption from prosecution.
- Section 20-2-115 Composition of review committee.
- Section 20-2-116 Certification in subspecialty of oncology required; certification by State Board of Medical Examiners; recertification.
- Section 20-2-117 Contracts for receipt of cannabis; Board of Medical Examiners to promulgate guidelines, rules and regulations.
- Section 20-2-118 Annual reports to Governor and Legislature.
- Section 20-2-119 Enumeration as Schedule I or II substance inapplicable.
- Section 20-2-120 Penalties.
- Section 20-2-140 Short title.
- Section 20-2-141 Definitions.
- Section 20-2-142 Legislative intent.
- Section 20-2-143 Manufacture, distribution, possession, or advertisement of imitation controlled substances prohibited; penalties; immunity of certain persons from liability.
- Section 20-2-144 Exceptions.
- Section 20-2-180 Definitions.
- Section 20-2-181 Board to designate by rule listed precursor chemicals; interim list established.
- Section 20-2-182 License required for furnishing listed precursor chemical; licensing procedure; record of transactions.
- Section 20-2-183 Permit for possession; requirements to receive permit; copies.
- Section 20-2-184 Denial, suspension or revocation of license.
- Section 20-2-185 Reporting transactions - Board to supply form.
- Section 20-2-186 Procedure upon discovery of loss or theft of chemicals - Records - Audits and inspections of records.
- Section 20-2-187 Adoption of rules; administrative fees authorized.
- Section 20-2-188 Exceptions to requirements for sale or transfer of chemicals, and to licensing requirements.
- Section 20-2-189 Property rights in chemicals forfeited upon violation.
- Section 20-2-190 Penalties; sale of ephedrine, etc.; Alabama Methamphetamine Abuse Task Force.
- Section 20-2-210 Legislative findings.
- Section 20-2-211 Definitions.
- Section 20-2-212 Controlled substances prescription database program; powers and duties of department; trust fund.
- Section 20-2-213 Reporting requirements.
- Section 20-2-214 Limited access to database permitted for certain persons or entities.
- Section 20-2-215 Confidentiality of database.
- Section 20-2-216 Unauthorized disclosure of information; unauthorized access, alteration, or destruction of information.
- Section 20-2-217 Surcharge on controlled substance registration certificate for maintenance, etc., of database.
- Section 20-2-218 Reimbursement of certain costs incurred in compliance with article.
- Section 20-2-219 Financing of development, operation, etc., of database.
- Section 20-2-220 Liability for reporting.